Human TNBC Cells 72h Treatment with 4.5nM OTSSP167 MELK Inhibitor vs. DMSO Control

ChEBI2017-05-01 更新2026-07-12 收录

乳腺癌药物

激酶抑制剂药效评估

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-68691 数据链接链接失效反馈

官方服务：

资源简介：

Human TNBC Cells 72h Treatment with 4.5nM OTSSP167 MELK Inhibitor vs. DMSO Control

创建时间：

2017-05-01

In vitro evaluation of the anti-breast cancer properties and gene expression profiles of Thai traditional formulary medicine extracts

乳腺癌药物

传统医学抗癌机制

Breast cancer (BC) is a major public health problem leading cause of cancer death both in Thailand and worldwide. In 2020, BC is the third most common type of cancer in Thailand. The occurrence rate o

NIAID Data Ecosystem60

Selective inhibition of carbonic anhydrase IX activity, using compound SLC-149, displays limited anticancer effects in breast cancer cell lines

碳酸酐酶抑制剂

乳腺癌药物

Selective inhibition of carbonic anhydrase IX activity, using compound SLC-149, displays limited anticancer effects in breast cancer cell lines Descriptor: 4-[3-(2,4-difluorophenyl)-2-oxo-2,3-dihydro-

Protein Data Bank Japan2023-10-11 更新60

Additional file 3: of Association of tamoxifen resistance and lipid reprogramming in breast cancer

乳腺癌药物

肿瘤脂质代谢

Statistical analysis of triglycerides, free cholesterol and cholesterol esters, LMP assay, and LipidToxGreen staining. (XLSX 38 kb)

Figshare2018-08-25 更新50

A Multi- Kinase Inhibitor Modulates Pulmonary Hypertension in a Rodent Model

肺动脉高压动物模型

激酶抑制剂药效评估

Pulmonary hypertension (PH) and cancer pathophysiology share common signal transduction pathways leading to abnormal endothelial and smooth muscle cell interactions and angioproliferative vasculopathy

NIAID Data Ecosystem60

Supplementary Table 4 from Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes

激酶抑制剂药效评估

乳腺癌药物

Supplementary Table 4: Kinase inhibition/inhibitor toxicity association analysis for Group 3 cell lines.

Figshare2015-01-01 更新50